Mira Pharmaceuticals, Common Stock Investor Sentiment

MIRA Stock   1.22  0.06  4.69%   
About 60% of MIRA Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading MIRA Pharmaceuticals, Common stock suggests that many investors are alarmed at this time. The current market sentiment, together with MIRA Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use MIRA Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
  
few days ago at forbes.com         
Xenoblade Chronicles X Definitive Edition Review Theyre Dolls, Not Skells
Usa forbes News
over a week ago at simplywall.st         
Companies Like MIRA Pharmaceuticals Are In A Position To Invest In Growth
Simply Wall St News at Macroaxis
over a week ago at benzinga.com         
EXCLUSIVE MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition With Development Of Topi...
benzinga news
over a week ago at finance.yahoo.com         
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic ...
Yahoo News
over a week ago at finance.yahoo.com         
MIRA Makes Another Pain Management Stride
Yahoo News
over a week ago at finance.yahoo.com         
HomeVision and Restb.ai Partner to Bring Advanced Computer Vision to Collateral Underwriting
Yahoo News
over two weeks ago at thelincolnianonline.com         
Short Interest in MIRA Pharmaceuticals, Inc. Expands By 20.2
news
over two weeks ago at finance.yahoo.com         
MIRA Announces Approval of Important Testing
Yahoo News
over two weeks ago at benzinga.com         
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
benzinga news
over two weeks ago at finance.yahoo.com         
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
Yahoo News
over two weeks ago at newswire.com         
MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Ne...
news
over three weeks ago at globenewswire.com         
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Macroaxis News: globenewswire.com
over a month ago at www.macroaxis.com         
Acquisition by Erez Aminov of 500000 shares of MIRA Pharmaceuticals, subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
MIRA Pharmaceuticals Trading 6.2 percent Higher Should You Buy?
news
over a month ago at scmp.com         
Hong Kong hotels Lunar New Year occupancy rates above 90 percent but few big spenders
news
Far too much social signal, news, headlines, and media speculation about MIRA Pharmaceuticals, that are available to investors today. That information is available publicly through MIRA media outlets and privately through word of mouth or via MIRA internal channels. However, regardless of the origin, that massive amount of MIRA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MIRA Pharmaceuticals, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MIRA Pharmaceuticals, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MIRA Pharmaceuticals,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MIRA Pharmaceuticals, alpha.

MIRA Pharmaceuticals, Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Erez Aminov of 2000 shares of MIRA Pharmaceuticals, at 0.84 subject to Rule 16b-3
12/27/2024
2
Rising High Exclusive talk with pharmaceutical development company MIRA - TipRanks
01/16/2025
3
Acquisition by Erez Aminov of 500000 shares of MIRA Pharmaceuticals, subject to Rule 16b-3
02/20/2025
4
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
03/04/2025
5
Short Interest in MIRA Pharmaceuticals, Inc. Expands By 20.2
03/07/2025
6
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
03/13/2025
7
Xenoblade Chronicles X Definitive Edition Review Theyre Dolls, Not Skells
03/19/2025

Complementary Tools for MIRA Stock analysis

When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance